Skip to content

Clinical trials

Completed Phase 2 Breast Neoplasms, Male trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms, Male Phase: Phase 2 Status: Completed Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
20025
20033
20048
200512
20062
20079
20083
20098
20103
20111
20132
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
Alliance for Clinical Trials in Oncology12
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
University of Washington3
Case Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
NCIC Clinical Trials Group2
National Institutes of Health Clinical Center (CC)2
UNICANCER2
Wake Forest University Health Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms, Male72
Breast Neoplasms70
Neoplasm Metastasis5
Triple Negative Breast Neoplasms5
Brain Neoplasms4
Inflammatory Breast Neoplasms4
Cardiotoxicity2
Testicular Neoplasms2
Blast Crisis1
Breast Carcinoma In Situ1

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.